AKINA, INC.

West Lafayette, IN · Biotech · Private

3-month injectable buprenorphine PLGA microparticle formulation for opioid use disorder treatment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · polyscitech.com

Sector: Biotech
Headquarters: West Lafayette, IN
Total capital: $3.3M

Federal grants: $320K; 1 award · 2023; Rank in peer group#448 of 502
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $3M; 5 awards · Health and Human S, Defense; Rank in Biotech#110 of 4373
Granted patents: 4; 17 pending · first 2018; Rank in peer group#22 of 502

Capital timeline

Latest events

Dec 2025Federal contractDefense · Scalable Homeland Innovative Enterprise Layered Defense (shield) Initial Order.$500
Sep 2023Federal contractHealth and Human S · This Is A Firm Fixed Price Fornew Plga Analytical Methods For Mini-size Complex Long-acting Injectable Formulations.$1.2M
Sep 2023Federal grantHealth and Human S · Phase I · Injectable 3-month buprenorphine PLGA microparticle formulation$320K
Sep 2019Federal contractHealth and Human S · Baa PMQWP#187 "new Analytical Methods For Complex Sameness Of Injectable, Long-acting Plga Formulations"$992K
Sep 2016Federal contractHealth and Human S · Igf::cl::igf Baa Contract Advanced Analytical Techniques For Mixed Polymer Drug-delivery Systems$549K
Sep 2014Federal contractHealth and Human S · Igf::ot::igf$208K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 502 peers

Line = median

Biotech · Molecule

Federal grantsBelow median
Granted patents#22 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 21

Jan 9, 2025PendingSynthesis Of Environmentally Degradable Alkyl PolyestersUSPTOApplication 18886673
Oct 22, 2024GrantedSynthesis Of Environmentally Degradable Alkyl PolyestersUSPTOUS 12,122,870
Jun 20, 2024PendingSynthesis Of Environmentally Degradable Alkyl PolyestersUSPTOApplication 18332724

Show all 21 patent records

Synthesis Of Environmentally Degradable Alkyl PolyestersJan 9, 2025 · Application 18886673Pending
Synthesis Of Environmentally Degradable Alkyl PolyestersOct 22, 2024 · US 12,122,870Granted
Synthesis Of Environmentally Degradable Alkyl PolyestersJun 20, 2024 · Application 18332724Pending
Biodegradable Polymer Formulations For Extended Efficacy Of Botulinum ToxinFeb 23, 2021 · US 10,925,837Granted
Biodegradable Microcapsules Containing Filling MaterialDec 17, 2020 · Application 16883917Pending
Sol-Gel Phase-Reversible Hydrogel Templates and Uses ThereofNov 19, 2019 · US 10,478,398Granted
Biodegradable Microcapsules Containing Filling MaterialJul 5, 2018 · Application 15832368Pending
Device For Large-scale Microparticle Production And Method Of Using The SameJan 2, 2018 · US 9,855,218Granted
Biodegradable Microcapsules Containing Filling MaterialSep 24, 2015 · Application 14429304Pending
Sol-Gel Phase-Reversible Hydrogel Templates and Uses ThereofJun 4, 2015 · Application 14617804Pending
Device For Large-Scale Microparticle Production And Method Of Using The SameApplication 61832297Pending
Sol-gel Phase-reversible Hydrogel Templates And Uses ThereofApplication PCTUS2008011260Pending
Readily Shapeable Xerogels Having Controllably Delayed Swelling PropertiesApplication PCTUS2006029482Pending
Fast Melting Tablets Having Taste-masking And Sustained Release PropertiesApplication PCTUS2005040073Pending
Synthesis Of Environmentally Degradable Alkyl PolyestersApplication PCTUS2021070743Pending
Highly Plastic Granules For Making Fast Melting TabletsApplication PCTUS2004014482Pending
Synthesis Of Environmentally Degradable Alkyl PolyestersApplication 63352938Pending
Biodegradable Polymer Formulations For Extended Efficacy Of Botulinum ToxinApplication PCTUS2017048174Pending
Long-acting Injectable, Biodegradable Compressed FormulationsApplication 63435260Pending
Biodegradable Polymer Formulations For Extended Efficacy Of Botulinum ToxinApplication 62380229Pending
Device For Large-scale Microparticle Production And Method Of Using The SameApplication PCTUS2014041583Pending

BOLDER BIOTECHNOLOGY INCSimilar federal contract value in Biotech · $3.1M in contracts
BIOMATRICA, INC.Similar federal contract value in Biotech · $3M in contracts
APOGEE BIOTECHNOLOGY CORPORATIONSimilar federal contract value in Biotech · $3M in contracts
ACTIVE MOTIF, INC.Similar federal contract value in Biotech · $2.9M in contracts
ARUNA BIO, INC.Similar federal contract value in Biotech · $2.9M in contracts
STC BIOLOGICS, INCSimilar federal contract value in Biotech · $2.8M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.